Tim Draper discusses Basepair, a genomics data platform that sits between sequencing providers and discovery companies. The platform handles analytics and data management while staying neutral, with HIPAA and GDPR compliance built in for privacy and security.
So on the one end you have Illumina that runs the sequencing, right? Yes, exactly. On the other hand, you have Pfizer or somebody who has all the data. Exactly. Why do they need you in the middle?
Yeah, that's a fair question. And it is very clear to us that rather than being the one making the discovery, we want to be the tool that all the discovery companies use. Exactly. That's a great question. So Illumina, you can spend a few hundred thousand dollars, buy the machine.
Yeah.
The machine runs for a day and now you have all the raw data output. Yeah. And then you need the insight, and that is where you need Basepair.
You don't think you'll be squeezed by Illumina and Pfizer or whoever?
In fact, the market is growing so quickly, we are seeing more and more opportunity.
Do you need some sort of privacy settings in order to aggregate this data and sell it for other—
Of course. That's one of the benefits of platform. It's completely secure. We have HIPAA, GDPR, AWS, a whole bunch of certifications.